How to buy Orthofix Medical stock

Orthofix Medical Inc is a medical devices business based in the US. Orthofix Medical shares (OFIX) are listed on the NASDAQ and all prices are listed in US Dollars. Orthofix Medical employs 1,036 staff and has a trailing 12-month revenue of around 0.00.

Orthofix Medical share price

Use our graph to track the performance of OFIX stocks over time.

Orthofix Medical shares at a glance

• Key figures

Information last updated 2021-04-23.

52-week range	$28.03 - $48.50
50-day moving average	$44.20
200-day moving average	$40.65
Wall St. target price	$54.00
PE ratio	343.3846
Dividend yield	N/A (0%)
Earnings per share (TTM)	$0.13

Buy Orthofix Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Orthofix Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Orthofix Medical Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Orthofix Medical under- or over-valued?

Valuing Orthofix Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Orthofix Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Orthofix Medical's P/E ratio

Orthofix Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 343x. In other words, Orthofix Medical shares trade at around 343x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Orthofix Medical's PEG ratio

Orthofix Medical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.1. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Orthofix Medical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Orthofix Medical's EBITDA

Orthofix Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $21.1 million.

The EBITDA is a measure of a Orthofix Medical's overall financial performance and is widely used to measure a its profitability.

Orthofix Medical financials

Revenue TTM	$406.6 million
Gross profit TTM	$304.7 million
Return on assets TTM	-1.61%
Return on equity TTM	0.74%
Profit margin	0.62%
Book value	$18.37
Market capitalisation	$882.9 million

TTM: trailing 12 months

Shorting Orthofix Medical shares

There are currently 336,574 Orthofix Medical shares held short by investors – that's known as Orthofix Medical's "short interest". This figure is 16.5% down from 403,139 last month.

There are a few different ways that this level of interest in shorting Orthofix Medical shares can be evaluated.

Orthofix Medical's "short interest ratio" (SIR)

Orthofix Medical's "short interest ratio" (SIR) is the quantity of Orthofix Medical shares currently shorted divided by the average quantity of Orthofix Medical shares traded daily (recently around 96995.389048991). Orthofix Medical's SIR currently stands at 3.47. In other words for every 100,000 Orthofix Medical shares traded daily on the market, roughly 3470 shares are currently held short.

However Orthofix Medical's short interest can also be evaluated against the total number of Orthofix Medical shares, or, against the total number of tradable Orthofix Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Orthofix Medical's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Orthofix Medical shares in existence, roughly 20 shares are currently held short) or 0.0237% of the tradable shares (for every 100,000 tradable Orthofix Medical shares, roughly 24 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Orthofix Medical.

Find out more about how you can short Orthofix Medical stock.

Orthofix Medical share dividends

We're not expecting Orthofix Medical to pay a dividend over the next 12 months.

Orthofix Medical share price volatility

Over the last 12 months, Orthofix Medical's shares have ranged in value from as little as $28.03 up to $48.5. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Orthofix Medical's is 1.1517. This would suggest that Orthofix Medical's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Orthofix Medical overview

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Global Extremities segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations.

Frequently asked questions

• What percentage of Orthofix Medical is owned by insiders or institutions?

  Currently 3.04% of Orthofix Medical shares are held by insiders and 100.645% by institutions.

• How many people work for Orthofix Medical?

  Latest data suggests 1,036 work at Orthofix Medical.

• When does the fiscal year end for Orthofix Medical?

  Orthofix Medical's fiscal year ends in December.

• Where is Orthofix Medical based?

  Orthofix Medical's address is: 3451 Plano Parkway, Lewisville, TX, United States, 75056

• What is Orthofix Medical's ISIN number?

  Orthofix Medical's international securities identification number is: US68752M1080

• What is Orthofix Medical's CUSIP number?

  Orthofix Medical's Committee on Uniform Securities Identification Procedures number is: 68752M108